Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of CBL-514 for cellulite (Stage 2) sponsored by Caliway Biopharmaceuticals Co., Ltd. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellulite

Drugs mentioned

• CBL-514

Snippet

Sponsor: Caliway Biopharmaceuticals Co., Ltd. | Conditions: Cellulite | Phase 2 | Status: COMPLETED